How to Reconstitute GHRP-2: Step-by-Step Laboratory Reconstitution Protocol
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
How to Reconstitute GHRP-2: Step-by-Step Laboratory Reconstitution Protocol
GHRP-2 (Growth Hormone Releasing Peptide-2, D-Ala-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2, MW 817.97 g/mol, CAS 158861-67-7) is a synthetic hexapeptide GHSR-1a agonist supplied as a lyophilised white powder in a 10mL sterile glass vial containing 5mg of peptide. GHRP-2 is freely soluble in aqueous media and reconstitutes easily for GHSR-1a receptor pharmacology and GH axis cell model research applications.
Materials Required
- GHRP-2 5mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
- Refrigerator at 2–8°C for storage
Pre-Reconstitution Preparation
Inspect the GHRP-2 vial to confirm the lyophilised powder is white and intact with an unbroken seal. Remove from cold storage and allow to equilibrate to room temperature for 10 minutes. GHRP-2's hexapeptide structure and low molecular weight mean it dissolves almost instantaneously in aqueous media — equilibration is primarily to prevent condensation issues.
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe down the work surface with 70% isopropyl alcohol and allow to dry. Wear nitrile gloves throughout.
Step 2 — Swab both stoppers. Clean the rubber stoppers of both vials with separate fresh alcohol swabs. Air dry for 10 seconds each.
Step 3 — Draw 2mL of BAC water. Draw 2mL of bacteriostatic water into a sterile syringe.
Step 4 — Inject slowly along the vial wall. Insert the needle into the GHRP-2 vial and direct the BAC water slowly down the inner glass wall over 10–15 seconds. Avoid directing the stream onto the lyophilised powder directly.
Step 5 — Dissolve gently. Swirl gently for 15–20 seconds. GHRP-2 dissolves almost instantly — the solution should be clear and colourless within seconds of adding the solvent. Do not shake or vortex.
Step 6 — Inspect and label. Confirm full clarity. Label with reconstitution date, concentration (2.5mg/mL), and initials.
Resulting Concentration
Adding 2mL BAC water to a 5mg GHRP-2 vial yields a stock concentration of 2.5mg/mL (2500mcg/mL). For GHSR-1a receptor binding and cAMP/calcium flux assays in GH3 pituitary or HEK293-hGHSR-1a cell model preparations, working concentrations of 0.1nM–1µM are prepared by serial dilution into assay buffer or serum-free media.
Concentration Reference Table
| BAC Water Volume Added | Resulting Concentration |
|---|---|
| 1mL | 5.0mg/mL (5000mcg/mL) |
| 2mL | 2.5mg/mL (2500mcg/mL) |
| 5mL | 1.0mg/mL (1000mcg/mL) |
Storage Conditions and Stability
Store lyophilised GHRP-2 at −20°C prior to reconstitution. Once reconstituted, store at 2–8°C. Reconstituted GHRP-2 in BAC water is stable for up to 28 days under refrigeration. Do not freeze reconstituted solution. GHRP-2 is stable in standard aqueous buffers and cell culture media across a physiological pH range. For long-term working aliquot storage, prepare single-use microcentrifuge aliquots and store at −80°C to avoid repeated freeze-thaw degradation.
Troubleshooting Common Reconstitution Issues
Powder not dissolving: Although rare for small hexapeptides, if any powder adheres to the glass wall, gently tilt the vial and swirl to bring it into contact with the solvent. Do not heat the vial. If dissolution remains incomplete after 60 seconds of gentle swirling, the vial may have been compromised by moisture ingress — inspect for any signs of a previously broken seal.
Cloudy solution: A properly reconstituted solution should be clear and colourless. Cloudiness can indicate microbial contamination (do not use), peptide aggregation from incorrect pH or temperature, or introduction of particulate matter. Discard the vial if cloudiness persists after gentle swirling.
Foaming: If foam forms during injection, this typically indicates the solvent was injected too quickly or directly onto the powder. Allow foam to settle naturally — do not shake. Once settled, gently swirl until fully dissolved. Foaming is rarely an issue with small hexapeptides but can occur if injection speed is too fast.
Loss of compound on vial walls: Ensure all reconstituted solution is recovered by gently swirling the vial so the solution contacts all inner wall surfaces. For maximum recovery, invert the vial and draw from the stopper end using a syringe after dissolution is complete.
Research Application Notes
GHRP-2 is among the most potent synthetic GHSR-1a agonists, demonstrating higher receptor binding affinity than GHRP-6 in competitive radioligand assays, making it the preferred reference compound for maximum GHSR-1a activation studies. Unlike ipamorelin, GHRP-2 has modest activity at non-GHSR-1a receptors including corticotroph and lactotroph systems — include appropriate receptor-selective controls in multi-endpoint cell model studies to attribute signalling responses correctly to GHSR-1a. In comparative GHSR-1a pharmacology studies alongside ipamorelin and hexarelin, GHRP-2 provides a reference point for second-generation GHRP receptor pharmacology. GHRP-2 5mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
